Scaffold-Mediated Cellular and Acellular Delivery of Inducible BMP2-Lentivirus Promotes Atrophic Nonunion Fracture Healing without Heterotopic Ossification
Nonunions occur in 5-10% of fracture patients, and current treatments are expensive with variable success. Controllable, localized delivery of BMP2 using porous, degradable scaffolds may be a promising alternative. We designed tube-shaped cryogel scaffolds (chitosan-gelatin, CG; chitosan-agarose-gelatin, CAG) to deliver a doxycycline-inducible BMP2-lentivirus vector (BMP2-LV). Results showed that…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.